1. Home
  2. SHOP vs NVO Comparison

SHOP vs NVO Comparison

Compare SHOP & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shopify Inc.

SHOP

Shopify Inc.

N/A

Current Price

$145.91

Market Cap

192.7B

Sector

Technology

ML Signal

N/A

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

N/A

Current Price

$46.28

Market Cap

199.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHOP
NVO
Founded
2004
1923
Country
Canada
Denmark
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.7B
199.4B
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
SHOP
NVO
Price
$145.91
$46.28
Analyst Decision
Buy
Hold
Analyst Count
33
11
Target Price
$164.44
$51.00
AVG Volume (30 Days)
6.9M
9.7M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
3.19%
EPS Growth
N/A
N/A
EPS
0.71
N/A
Revenue
$11,556,000,000.00
N/A
Revenue This Year
$29.34
N/A
Revenue Next Year
$23.77
$3.70
P/E Ratio
$204.80
$13.60
Revenue Growth
30.14
N/A
52 Week Low
$94.00
$35.12
52 Week High
$182.19
$64.16

Technical Indicators

Market Signals
Indicator
SHOP
NVO
Relative Strength Index (RSI) 51.81 52.05
Support Level $144.12 $43.25
Resistance Level $171.94 $48.23
Average True Range (ATR) 4.64 0.98
MACD -2.02 0.07
Stochastic Oscillator 33.09 63.82

Price Performance

Historical Comparison
SHOP
NVO

About SHOP Shopify Inc.

Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Share on Social Networks: